Two current articles in the Journal of Rheumatology address issues surrounding mortality risk among those with new and established gout.
All News
Dr. Jack Cush reviews news and highlights from the past week on RheumNow.com.
Dr. Steven Carsons and an expert committee of the Sjogren's Syndrome Foundation have published a clinical practice guidelines (CPGs) and recommendations for the managment of Sjögren's syndrome.
A a randomized trial published in Annals of Internal Medicine shows that intradiscal glucocorticoid injection has limited (1 month) efficacy in treating low back pain (LBP) associated with active discopathy, yet decreased over time.
Dr. Jack Cush reviews this week's news and information from the 2017 RWCS meeting in Maui.
Dr. Jack Cush reviews highlights from this past week on RheumNow.com:
Dr. Jack Cush reviews highlights from the first week of 2017 on RheumNow.com.
Happy New Year!
ANCA associated vasculitis (AAV) has undergone considerable study and advances in the last few years.
Dr. Jack Cush reviews news and journal reports from the past week on RheumNow.com.
Highlights from this week on RheumNow.com include:
1. Having #RA in addition to solid cancer (breast, lung, prostate, colon) increases mortality rates by 40-50% in elders https://t.co/aitjusmOai
2. The global market for rheumatoid arthritis therapies was $19.9 billion in 2015, expected to reach $21.3B by 2020 https://t.co/d2Sh5C8y9f
3. Half of doctors never heard of MACRA:Medicare Access & CHIP Reauthorization Act. Starts on Jan 1st! https://t.co/eYgWBWCw6y Blog:https://t.co/sRKZSOFyNV
And more!
Dr Jack Cush reviews this week's highlights from RheumNow.com.
From tofacitinib developmental trials in RA and psoriasis and adherence to T2T in early RA to a rheumatology pearl about dapsone and much more, here are the highlights of what you may have missed on RheumNow.com this week.
SAPHO is an acronym that describes a constellation of findings (synovitis, acne, pustulosis, hyperostosis, and osteitis) that defines this rare syndrome.
Systemic lupus is a clinically heterogeneous disorder, unified by requisite clinical features and exuberant humoral response to unknown triggers. While the diagnosis is easy, the disease course and management can be complicated and challenging.
A Finnish early RA register studied 14,878 incident RA patients from 2000-2008 and identified 1157 deaths. Patients receiving DMARDs and MTX had lower mortality rates. The standardized mortality ratio for the entire cohort was reduced (0.57, 95% CI 0.52 to 0.62).
At the EULAR 2016 meeting, new EULAR recommendations for the management of Behçet's disease (BD) were presented.
The EULAR Annual European Congress of Rheumatology meeting was held in London from June 8-11, 2016 and was well attended by thousands. This year’s meeting had over 2,000 poster displays, and the EULAR 2016 Congress presented new recommendations on the management of rheumatoid arthritis, spondyloarthritis, and fibromyalgia.
The GiACTA study has published its top line results demonstrating the efficacy of adding tocilizumab (TCZ) to steroid-tapered therapy in patients with giant cell arteritis (GCA).
Glucocorticoid (or steroid) therapy is a well-known risk factor for diabetes. But what dose, given how and for how long? Dixon and colleagues from the The University of Manchester have quantified the risk of diabetes associated with steroid use.
